It’s become a bit of a tradition for the Foundation to send a Thanksgiving note, and this year we’re excited to support projects that have evolved as part of ongoing work by researchers and the Foundation.
As you know, we seek new ideas and collaborative approaches and in 2021 that has translated into: continued work with NIH supporting next generation research, funding an initial site for breast cancer treatment clinical trial from the lab of Andrea Bild, Ph.D., at City of Hope, helping personalize radiation therapy for breast cancer with Heiko Enderling, Ph.D., at Moffitt Cancer Center, as well as extending funding to further the PhysiCell project developed by Paul Macklin, Ph.D.
The Foundation again hosted its annual October symposium, highlighting findings from collaborative research and hear a keynote address from the Jayne Koskinas Annual Keynote Speaker, Lisa M. Coussens, Ph.D. And I would be remiss if I didn’t thank Team TGM for its ongoing support.
Enjoy Thanksgiving with friends and loved ones and thank you again for being part of JKTG’s work. Happy Thanksgiving!
Ted Giovanis, FHFMA, MBA
President and Founder
Foundation for the NIH and JKTG Foundation Renew Support for training two research fellows at the NIH
The Jayne Koskinas Ted Giovanis Foundation for Health and Policy (JKTG) is proud to announce renewed support for the intramural research training of two young fellows at the National Institutes of Health (NIH).
The Jayne Koskinas Ted Giovanis Foundation for Health and Policy has extended prior funding to Paul Macklin, a mathematician and associate professor of Intelligent Systems Engineering at Indiana University, to support additional development of the community-driven SARS-COV-2 tissue simulator.
The Jayne Koskinas Ted Giovanis Foundation for Health and Policy has extended prior JKTGF funded research to Heiko Enderling, Ph.D., a faculty member of Moffitt Cancer Center, to support his work personalizing radiation therapy to better fight breast cancer.